About 1 result found for searched term "1803171-55-2" (0.249 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21383 | Ravulizumab | Complement System |
| ALXN-1210; ALXN1210 | ||
| Ravulizumab (ALXN1210) is a humanized monoclonal antibody that binds with high affinity to complement protein C5 and inhibits terminal complement activation, Ravulizumab can be used for the researchs of COVID-19-associated severe pneumonia, acute lung injury and acute respiratory distress syndrome. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
